Today’s Gold News Updated By Gates Commodity

Gold was down on Thursday morning in Asia, with investor sentiment boosted by positive results from yet another potential COVID-19 vaccine.

U.S. pharmaceutical company Pfizer (NYSE:PFE) announced the results from the early stage human trial for BNT162b1, its mRNA candidate jointly developed with German biotech firm BioNTech (NASDAQ:BNTX), on Wednesday. The results showed production of neutralizing antibodies in all the patients who were inoculated after 28 days.

C/W @ 9941012480
www.gatescommodity.com
https://www.gatescommodity.com/month.php?id=8

Leave a Reply

Your email address will not be published. Required fields are marked *